EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cognitive Sarcopenia: Prevalence and the Risk for Mortality and Healthy Aging in the KORA‐Age Study

Marie-Theres Huemer iD, Barbara Thorand, Eva Grill, Lars Schwettmann, Annette Peters

Journal of Cachexia, Sarcopenia and Muscle · 2026

DOI: 10.1002/jcsm.70201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2026. Verfasst von Marie-Theres Huemer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany. Hauptthemen laut MEDLINE: Sarcopenia, Healthy Aging, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Education and Research, State of Bavaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive sarcopenia, defined by this study as the co‐existence of sarcopenia and cognitive impairment, has been frequently reported in older adults, while we hypothesize that the co‐existence increases the risk for adverse outcomes in the older general population.

Methods

This study included 1055 participants aged 65–93 years from the population‐based cohort Cooperative Health Research in the Region Augsburg (KORA)‐Age (2008/9). At baseline, probable sarcopenia (i.e., low grip strength) and confirmed sarcopenia (i.e., probable sarcopenia plus low muscle mass) were defined according to the European Working Group on Sarcopenia in Older People (EWGSOP) 2018 consensus. Cognitive impairment was derived from the modified telephone interview for cognitive status or a proxy interview with relatives/caregivers when participants had severe physical/mental impairment. Cognitive probable sarcopenia was defined as having both probable sarcopenia and cognitive impairment; cognitive confirmed sarcopenia as both confirmed sarcopenia and cognitive impairment. Isolated probable sarcopenia and isolated cognitive impairment refer to individuals with only one of the diseases. Mortality was assessed using death certificates over 12 years (553 deaths [52.4%]). Adverse outcomes were assessed in 2012 and 2016 during telephone interviews. Covariate‐adjusted logistic and Cox regression models estimated the associations with adverse outcomes and mortality, respectively.

Results

Almost 50% of older adults with probable sarcopenia had cognitive impairment, whereas among older adults without probable sarcopenia, only 20% had cognitive impairment. A total of 8.1% of the study population had cognitive probable sarcopenia, while 3.3% had cognitive confirmed sarcopenia. Muscle mass was not [OR (95% CI): 0.92 (0.70–1.20)], while grip strength [0.73 (0.57–0.94)], gait speed [0.66 (0.54–0.80)], and Timed Up and Go time [1.51 (1.27–1.82)] were associated with cognitive impairment. Participants with cognitive probable sarcopenia had an increased risk of all‐cause mortality [HR (95% CI): 1.95 (1.41–2.70)], cardiovascular disease mortality [1.64 (1.02–2.64)], and coronary heart disease mortality [2.10 (1.03–4.27)] after 12 years, and activities of daily living disability [OR (95% CI): 6.12 (2.33–16.06)] and requiring nursing care after 3 years [4.77 (1.47–14.63)]. Individuals with isolated probable sarcopenia or isolated cognitive impairment had either lower or no risk for those outcomes.

Conclusions

Since life expectancy and relevant healthcare have not advanced considerably since study baseline, we expect that these results are relevant today. The high prevalence of cognitive impairment in older adults with probable sarcopenia and the increased risk of cognitive sarcopenia on lifespan and independence endorse screening for cognitive impairment in older adults with probable sarcopenia by EWGSOP 2018 and support exploring intervention studies targeting both diseases simultaneously.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaHealthy AgingCognitive DysfunctionHumansAgedMaleFemalePrevalenceAged, 80 and overRisk FactorsCognition

Stichwörter der Autor:innen

activities of daily livingcognitive impairmentcognitive sarcopeniamortalitynursing caresarcopenia

Autor:innen und Institutionen

  • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
  • Institute for Medical Information Processing, Biometry and Epidemiology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.
  • German Center for Vertigo and Balance Disorders, DSGZ, Faculty of Medicine, Ludwig-Maximilians Universität Munich (LMU), Munich, Germany.
  • Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
  • Department of Health Services Research, School of Medicine and Health Sciences, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.

ORCID-Profile: Marie-Theres Huemer

Förderung

  • German Federal Ministry of Education and Research
  • State of Bavaria

Zitieren

APA

Huemer, M. T., Thorand, B., Grill, E., Schwettmann, L., & Peters, A. (2026). Cognitive Sarcopenia: Prevalence and the Risk for Mortality and Healthy Aging in the KORA‐Age Study. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70201

Vancouver

Huemer MT, Thorand B, Grill E, Schwettmann L, Peters A. Cognitive Sarcopenia: Prevalence and the Risk for Mortality and Healthy Aging in the KORA‐Age Study. Journal of Cachexia, Sarcopenia and Muscle. 2026. doi:10.1002/jcsm.70201

BibTeX
@article{Huemer2026,
  author = {Huemer, Marie-Theres and Thorand, Barbara and Grill, Eva and Schwettmann, Lars and Peters, Annette},
  title = {Cognitive Sarcopenia: Prevalence and the Risk for Mortality and Healthy Aging in the KORA‐Age Study},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  doi = {10.1002/jcsm.70201}
}
Kostenlos starten →